Spinach

For diagnostic purposes, the dosage of Spinach extract is highly standardized based on the method of administration.

• Skin Prick Test (SPT): One drop of the non-standardized extract (typically at a concentration of 1:10 or 1:20 weight/volume) is applied to the skin, usually on the forearm or back. A sterile lancet is then used to prick the skin through the drop.
• Intradermal Test: If the SPT is negative, a clinician may administer 0.02 mL to 0.05 mL of a 1:100 or 1:1000 dilution of the extract via a small needle into the dermal layer of the skin.

Spinach extract is used in pediatric populations for allergy diagnosis. The procedure is identical to the adult protocol; however, clinicians often use fewer test sites to minimize distress. There is no specific age-based dose adjustment, but the interpretation of the wheal size may differ based on the child's skin reactivity and age. It is generally not recommended for infants under 6 months of age unless strictly necessary, as skin reactivity may be inconsistent.

Renal Impairment

No dosage adjustments are required for patients with renal impairment, as the systemic exposure to the extract during diagnostic testing is minimal. However, patients with end-stage renal disease may have altered skin reactivity (uremic pruritus or decreased inflammatory response), which could interfere with test interpretation.

Hepatic Impairment

No dosage adjustments are necessary for patients with hepatic impairment. The metabolic pathway of the small amount of protein absorbed does not rely on primary hepatic CYP450 pathways.

Elderly Patients

Elderly patients may exhibit reduced skin reactivity due to age-related changes in skin turgor and mast cell density. While no specific dose adjustment is needed, clinicians should be aware that a smaller wheal size may still indicate a significant allergy in this population.

Spinach allergenic extract is never self-administered by the patient. It is strictly for professional use in a clinical environment.

• Preparation: The skin site (usually the volar surface of the forearm) is cleaned with alcohol and allowed to dry.
• Application: Drops are placed at least 2-3 cm apart to prevent overlapping reactions.
• Timing: The reaction is typically read 15 to 20 minutes after the prick is performed.
• Storage: Vials must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze, as this can denature the allergenic proteins and render the extract ineffective.

Since Spinach extract is used for one-time diagnostic testing or scheduled immunotherapy, a 'missed dose' usually refers to a missed appointment. If a diagnostic test is missed, it can be rescheduled at any time. If an immunotherapy dose is missed, the healthcare provider will determine if the dose needs to be reduced to prevent an adverse reaction upon resumption.

An 'overdose' in the context of Spinach extract would involve the administration of too much extract or an inappropriately high concentration, leading to a systemic allergic reaction (anaphylaxis).

• Signs of Overdose: Rapid onset of hives, swelling of the throat (angioedema), wheezing, difficulty breathing, or a drop in blood pressure (hypotension).
• Emergency Measures: Administration of epinephrine (0.3 mg for adults) is the first-line treatment. The patient should be placed in the recumbent position, and emergency medical services must be contacted immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not attempt to use allergenic extracts outside of a supervised medical setting.

The most frequent side effects associated with Spinach extract are localized to the site of administration. These are expected physiological responses to the test.

• Local Wheal: A raised, pale, or skin-colored bump at the test site, similar to a mosquito bite. This typically peaks at 15-20 minutes and resolves within 1-2 hours.
• Erythema (Flare): Redness surrounding the wheal caused by the dilation of local blood vessels. This may feel warm to the touch.
• Pruritus (Itching): Intense itching at the site of the prick. Patients are advised not to scratch, as this can cause skin trauma or alter the test results.

• Persistent Swelling: In some patients, the local reaction may progress into a 'late-phase reaction,' where the swelling returns or worsens 4 to 8 hours after the test.
• Local Pain: A mild stinging or burning sensation at the site of the lancet prick or intradermal injection.
• Lymphangitis: Very rarely, red streaks may appear extending from the test site, indicating temporary lymphatic irritation.

• Systemic Urticaria: Hives appearing on parts of the body far away from the test site.
• Vasovagal Reaction: Fainting or lightheadedness triggered by the needle prick or the sight of blood/needles, rather than the extract itself.
• Infection: As with any procedure that breaks the skin, there is a very slight risk of localized cellulitis or a small abscess at the injection site.

> Warning: Stop the procedure and call for emergency help immediately if you experience any of the following symptoms of anaphylaxis:

• Respiratory Distress: Sudden shortness of breath, wheezing, or a high-pitched sound when breathing (stridor).
• Upper Airway Obstruction: Feeling of a 'lump in the throat,' hoarseness, or difficulty swallowing.
• Cardiovascular Collapse: Rapid or weak pulse, dizziness, confusion, or loss of consciousness.
• Gastrointestinal Distress: Severe abdominal cramping, vomiting, or diarrhea occurring immediately after the test.

Spinach extract used for diagnostic purposes does not typically have long-term side effects. However, repeated exposure through immunotherapy can, in very rare cases, lead to 'serum sickness-like' reactions, characterized by joint pain, fever, and rashes, though this is not commonly documented for spinach-specific extracts.

Spinach allergenic extracts, like all allergenic extracts, carry a significant warning regarding the risk of severe systemic reactions.

FDA-Style Warning Summary: This product can cause severe life-threatening systemic reactions, including anaphylaxis. It must only be administered by healthcare providers experienced in the diagnosis and treatment of allergic diseases. Patients must be observed for at least 30 minutes following administration. Patients with unstable asthma or those taking beta-blockers may be at increased risk of severe outcomes or may be resistant to standard resuscitation measures.

Report any unusual symptoms to your healthcare provider immediately.

Spinach extract is a potent immunological tool. Its use is contraindicated in patients who have previously had a life-threatening reaction to spinach or any component of the extract (such as glycerin or phenol). It should only be used in facilities where emergency resuscitation equipment, including oxygen and epinephrine, is immediately available.

No specific individual 'Black Box' exists for Spinach specifically, but it falls under the General Boxed Warning for Allergenic Extracts. The warning emphasizes that systemic reactions are a constant risk. The risk is higher with intradermal testing compared to skin prick testing. Healthcare providers must ensure the patient is not currently experiencing an asthma exacerbation, as this significantly increases the risk of a fatal reaction.

• Allergic Reactions / Anaphylaxis Risk: The primary risk is a systemic allergic reaction. Patients with a high degree of sensitivity may react even to the very small amounts used in skin testing.
• Asthma Status: Patients with poorly controlled or unstable asthma are at a much higher risk for severe bronchospasm during testing. Testing should be postponed until the asthma is stable.
• Skin Conditions: Patients with extensive dermatitis, eczema, or dermographism may produce false-positive results, making the test uninterpretable.
• Beta-Blocker Use: Patients taking beta-blockers (e.g., metoprolol, propranolol) may not respond to epinephrine if an allergic reaction occurs. This is a critical safety consideration.

• Post-Test Observation: Patients must remain in the clinic for a minimum of 30 minutes after the test is performed.
• Baseline Vital Signs: Heart rate and blood pressure should be checked if the patient has a history of cardiovascular disease.
• Lung Function: In asthmatic patients, a peak flow or spirometry test may be performed before testing to ensure respiratory stability.

Spinach extract does not typically cause sedation. However, if a systemic reaction occurs or if the patient experiences a vasovagal (fainting) episode, they should not drive until fully recovered and cleared by a physician.

Alcohol consumption should be avoided for 24 hours before and after testing. Alcohol can increase peripheral vasodilation, which may potentially enhance the rate of allergen absorption or exacerbate a localized skin reaction.

There are no withdrawal symptoms associated with Spinach extract. However, if a patient is undergoing immunotherapy, stopping the treatment abruptly will result in the loss of desensitization, and the patient will return to their baseline level of allergy.

> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Spinach extract testing.

• Beta-Blockers (Non-selective and Selective): Drugs like propranolol, atenolol, and carvedilol can make anaphylaxis more severe and render epinephrine (the emergency treatment) ineffective. Testing should only proceed if the benefits outweigh the risks and under extreme caution.

• ACE Inhibitors: Drugs like lisinopril or enalapril may interfere with the body's compensatory mechanisms during an allergic reaction, potentially worsening angioedema (swelling of the face/throat).
• MAO Inhibitors: Monoamine oxidase inhibitors can potentiate the effects of epinephrine, which may be a concern if emergency treatment is required.

• Antihistamines (H1 Blockers): Medications like cetirizine (Zyrtec), loratadine (Claritin), and diphenhydramine (Benadryl) will suppress the skin's reaction to the Spinach extract, leading to a false-negative result. These must be discontinued 3 to 7 days before testing.
• H2 Blockers: Drugs like famotidine (Pepcid) can also mildly suppress skin reactivity and should be discontinued 48 hours before testing.
• Tricyclic Antidepressants (TCAs): Amitriptyline and others have potent antihistamine properties and can interfere with test results for up to 2 weeks.

• Cross-Reactive Foods: Patients allergic to spinach may also react to other members of the Chenopodiaceae family (e.g., beets, chard) or the Amaranthaceae family. This is known as cross-reactivity and can complicate the interpretation of the test.
• Latex: Some patients with a latex allergy may show sensitivity to spinach due to 'latex-fruit syndrome,' where similar proteins are found in both substances.

• St. John's Wort: May theoretically affect the metabolism of medications used to treat allergic reactions.
• High-Dose Vitamin C: Some studies suggest Vitamin C has mild antihistamine effects, which could theoretically dampen the skin prick response.

• Skin Tests: Spinach extract is itself a 'test.' Its presence in the system does not typically interfere with blood-based lab tests like a CBC or metabolic panel, but it will interfere with other simultaneous skin tests if the reactions are too close together.

> Important: Tell your doctor about ALL medications, including over-the-counter allergy pills and herbal supplements, before your Spinach extract test.

Spinach extract must NEVER be used in the following circumstances:

• Previous Severe Anaphylaxis to Spinach: If a patient has a documented history of near-fatal anaphylaxis upon eating spinach, skin testing may be too dangerous and a blood test (IgE RAST/ImmunoCAP) is preferred.
• Unstable Asthma: Patients with a Forced Expiratory Volume (FEV1) of less than 70% of predicted or those with recent hospitalizations for asthma should not undergo testing due to the risk of fatal bronchospasm.
• Acute Infection: Testing should not be performed during a systemic viral or bacterial infection, as the immune system is already primed and results may be skewed.

• Pregnancy: While not strictly forbidden, diagnostic skin testing is usually postponed until after delivery to avoid the risk of maternal anaphylaxis, which can cause fetal hypoxia (lack of oxygen).
• Severe Atopic Dermatitis: If there is no clear area of healthy skin on the back or arms, the test cannot be accurately performed.
• Beta-Blocker Therapy: As noted, this increases the risk of treatment-resistant anaphylaxis.

Patients should be aware of cross-sensitivity with:

• Beets and Swiss Chard: These are botanically related to spinach.
• Molds: Some research suggests cross-reactivity between certain fungal spores and plant proteins.
• Pollen: Patients with 'Oral Allergy Syndrome' related to weed pollens (like Ragweed) may have a localized mouth reaction to spinach, but this is distinct from a true systemic spinach allergy.

> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to foods or latex, before prescribing Spinach extract.

Spinach extract is classified under FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted. The primary concern is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis during pregnancy can lead to uterine contractions, placental hypoperfusion, and fetal distress or death. Therefore, diagnostic testing with Spinach extract is generally avoided during pregnancy unless the information is vital for the immediate management of the patient.

It is not known whether the allergenic proteins in Spinach extract are excreted in human milk. However, because the amount used in diagnostic testing is so small and the proteins are rapidly degraded locally, the risk to a nursing infant is considered negligible. Breastfeeding mothers should be observed for systemic reactions as usual.

Spinach extract is safe and effective for use in children as young as infants for the diagnosis of food allergy. However, clinicians must be cautious as children have a higher surface-area-to-volume ratio and may be more sensitive to systemic effects. The use of Spinach extract for immunotherapy in children under 5 is generally not recommended due to the difficulty of monitoring for early signs of anaphylaxis in this age group.

Clinical studies of Spinach allergenic extracts did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In general, elderly patients have thinner skin and fewer mast cells, which may lead to smaller wheal diameters. Additionally, the elderly are more likely to have underlying cardiovascular disease, making them more vulnerable to the effects of a systemic reaction or the epinephrine used to treat it.

In patients with chronic kidney disease (CKD), the skin may be less reactive to histamine and allergens. This can lead to false-negative results. No dose adjustment is needed, but a positive histamine control must be used to ensure the skin is capable of reacting.

There are no specific concerns for patients with liver disease. The proteins in Spinach extract are not processed by the liver in a way that would be affected by cirrhosis or hepatitis.

> Important: Special populations, particularly pregnant women and the elderly, require a careful risk-benefit analysis by an allergist before testing.

Spinach extract functions as an exogenous antigen. The primary molecular mechanism involves the binding of spinach-derived glycoproteins to bivalent IgE antibodies on the surface of mast cells. This binding causes the aggregation of FcεRI receptors, which triggers an intracellular signaling cascade involving tyrosine kinases (such as Syk). This leads to the influx of calcium ions and the subsequent exocytosis of pre-formed mediators (histamine, heparin) and the de-novo synthesis of lipid mediators (leukotrienes). In a diagnostic setting, this localized reaction is a proxy for the patient's systemic allergic sensitivity.

• Onset of Action: The wheal and flare reaction typically begins within 5 minutes of administration.
• Peak Effect: The maximum reaction size is usually reached between 15 and 20 minutes.
• Duration: The visible skin reaction typically fades within 1 to 2 hours, although cellular infiltration (late-phase reaction) can persist for up to 24 hours.

| Parameter | Value |

|---|---|

| Bioavailability | Negligible (Epicutaneous) |

| Protein Binding | Local tissue binding |

| Half-life | Local degradation within hours |

| Tmax | 15-20 minutes (for reaction) |

| Metabolism | Proteolytic cleavage |

| Excretion | Lymphatic clearance |

• Molecular Components: Contains So l 1 (a profilin), So l oxalic acid, and various rubisco proteins.
• Solubility: Soluble in aqueous solutions and glycerol-based buffers.
• Formulation: Typically contains 50% glycerin, 0.45% NaCl, and 0.4% phenol as a preservative.

Spinach extract is classified as a Non-Standardized Food Allergenic Extract. Unlike 'Standardized' extracts (like Ragweed or Grass), the potency of Spinach extract is measured by weight/volume (w/v) or Protein Nitrogen Units (PNU) rather than bioequivalent allergy units (BAU).